Inhibrx Biosciences, Inc. (INBX)

CIK 2007919 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Inhibrx Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Oct 28, 2026SCHEDULE 13G/A0000070858-26-000526
Oct 14, 202640001366074-26-000006
Sep 28, 20268-K0002007919-26-000050
Sep 28, 202640001366074-26-000004
Sep 23, 202640001366268-26-000011
Sep 18, 20264/A0001612627-26-000007
Sep 18, 20264/A0001240801-26-000006
Sep 18, 20264/A0001366268-26-000009
Sep 18, 20264/A0001202094-26-000009
Sep 17, 202640001366268-26-000006
Sep 15, 20261440001959173-26-006980
Sep 15, 202640001202094-26-000006
Sep 14, 20261440001959173-26-006953
Sep 11, 20261440001959173-26-006886
Sep 10, 202640001202094-26-000004
Sep 9, 20261440001959173-26-006844
Sep 8, 202640001366268-26-000004
Sep 8, 202640001240801-26-000004
Sep 8, 20261440001959173-26-006805
Sep 8, 202640001366074-26-000002
Sep 8, 20268-K0002007919-26-000047
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352639
Aug 14, 2026SCHEDULE 13G/A0000905148-26-003736
Aug 14, 2026SCHEDULE 13G0001193805-26-001095
Aug 13, 202610-Q0002007919-26-000042